X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (59) 59
index medicus (51) 51
humans (48) 48
female (36) 36
cancer (31) 31
adult (29) 29
hematology, oncology and palliative medicine (29) 29
middle aged (29) 29
male (25) 25
chemotherapy (23) 23
aged (21) 21
survival (21) 21
prognosis (20) 20
sarcoma (20) 20
analysis (17) 17
sarcoma - drug therapy (17) 17
metastasis (16) 16
clinical trials (15) 15
treatment outcome (15) 15
disease-free survival (14) 14
breast cancer (12) 12
research (12) 12
soft tissue sarcoma (12) 12
follow-up studies (11) 11
oncology, experimental (11) 11
care and treatment (10) 10
doxorubicin (9) 9
kaplan-meier estimate (9) 9
pazopanib (9) 9
retrospective studies (9) 9
sarcoma - mortality (9) 9
tumors (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
disease progression (8) 8
efficacy (8) 8
proportional hazards models (8) 8
adjuvant treatment (7) 7
drug therapy (7) 7
expression (7) 7
neoplasm staging (7) 7
patient outcomes (7) 7
patients (7) 7
randomized controlled trials as topic (7) 7
sarcoma - pathology (7) 7
statistics & probability (7) 7
young adult (7) 7
adolescent (6) 6
aged, 80 and over (6) 6
anthracyclines (6) 6
breast neoplasms - mortality (6) 6
metastases (6) 6
prospective studies (6) 6
solid tumors (6) 6
surgery (6) 6
therapy (6) 6
adjuvant chemotherapy (5) 5
biomarkers (5) 5
breast neoplasms - pathology (5) 5
breast neoplasms - therapy (5) 5
clinical-trials (5) 5
development and progression (5) 5
double-blind (5) 5
doxorubicin plus ifosfamide (5) 5
european-organization (5) 5
ifosfamide (5) 5
life sciences (5) 5
pyrimidines - therapeutic use (5) 5
randomized phase-ii (5) 5
recurrence (5) 5
risk (5) 5
safety (5) 5
soft tissue neoplasms - drug therapy (5) 5
soft tissue neoplasms - mortality (5) 5
soft-tissue sarcoma (5) 5
sulfonamides - therapeutic use (5) 5
survival rate (5) 5
1st-line treatment (4) 4
article (4) 4
breast neoplasms - drug therapy (4) 4
clinical trials as topic (4) 4
colony-stimulating factor (4) 4
combined modality therapy (4) 4
doxorubicin - administration & dosage (4) 4
eortc (4) 4
europe (4) 4
gastrointestinal stromal tumors (4) 4
guidelines (4) 4
lymphatic metastasis (4) 4
mathematical & computational biology (4) 4
models (4) 4
multicenter (4) 4
neoadjuvant chemotherapy (4) 4
neoplasm metastasis (4) 4
neoplasms - pathology (4) 4
neoplasms - therapy (4) 4
phase-ii (4) 4
prognostic-factors (4) 4
progression-free survival (4) 4
recist (4) 4
recommendations (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 10/2019, Volume 120, pp. 47 - 53
EORTC (European Organisation of Research and Treatment of Cancer) 62024 is a phase III randomised trial evaluating adjuvant imatinib in patients with... 
Imatinib | Surgical reporting | Surgical treatment | Adjuvant treatment | Gastro-intestinal stromal tumor | Quality assessment | Surgical oncology trials | TRIALS | DIAGNOSIS | GIST | RESECTION | CANCER | ONCOLOGY | GRADE | RECURRENCE | Endoscopes | Surgery | Rupture | Questionnaires | Surgeons | Laparoscopy | Endoscopy | Patients | Tumors
Journal Article
Lancet Oncology, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 415 - 423
Journal Article
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 03/2017, Volume 14, Issue 3, pp. 187 - 192
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 06/2018, Volume 142, Issue 12, pp. 2610 - 2620
Journal Article